[HTML][HTML] Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

M Budak, JM Cicchese, P Maiello… - PLOS Computational …, 2023 - journals.plos.org
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.

M Budak, JM Cicchese, P Maiello… - PLoS …, 2023 - search.ebscohost.com
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: comparing the standard regimen with Moxifloxacin-containing regimens

M Budak, JM Cicchese, P Maiello, HJ Borish, AG White… - bioRxiv, 2022 - biorxiv.org
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

[HTML][HTML] Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

M Budak, JM Cicchese, P Maiello… - PLOS Computational …, 2023 - ncbi.nlm.nih.gov
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing Tuberculosis Treatment Efficacy: comparing the Standard Regimen with Moxifloxacin-containing Regimens

M Budak, J Linderman, JA Flynn, D Kirschner - 2023 - ASPET
Abstract ID 19313 Poster Board 151 Tuberculosis (TB) continues to be one of the deadliest
infectious diseases in the world, causing∼ 1.5 million deaths every year. The World Health …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

JM Cicchese, P Maiello, HJ Borish… - PLoS …, 2023 - search.proquest.com
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

M Budak, JM Cicchese, P Maiello… - PLoS …, 2023 - ui.adsabs.harvard.edu
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.

M Budak, JM Cicchese, P Maiello… - Plos Computational …, 2023 - europepmc.org
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens

M Budak, JM Cicchese, P Maiello… - PLoS computational … - pubmed.ncbi.nlm.nih.gov
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.

M Budak, JM Cicchese, P Maiello… - Plos Computational …, 2023 - europepmc.org
Tuberculosis (TB) continues to be one of the deadliest infectious diseases in the world,
causing~ 1.5 million deaths every year. The World Health Organization initiated an End TB …